The Association Between Obesity and COVID-19 Severity in Children Differed Between SARS-CoV-2 Variants: A

Yanshan Zhu1, Petra Zimmermann2,3,4, Daniel K Yeoh5,6

  • 1From the School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.

Insights

Obesity increased severe COVID-19 risk in children during earlier SARS-CoV-2 variants. This association was not observed during the Omicron wave, even in unvaccinated children, indicating changing disease dynamics.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Obesity posed a significant risk for severe COVID-19 in children during the ancestral and Delta variant waves.
  • The impact of obesity on pediatric COVID-19 severity during the Omicron variant surge remained undetermined.

Purpose of the Study:

  • To investigate the association between childhood obesity and COVID-19 severity during different SARS-CoV-2 variant waves.
  • To determine if vaccination status influenced the relationship between obesity and respiratory support needs.

Main Methods:

  • A multicenter, observational study analyzed hospitalized children and adolescents with confirmed SARS-CoV-2 infection.
  • Data spanned three periods: ancestral strain (T1), pre-Omicron variants (T2), and Omicron (T3).
  • The primary outcome measured was the requirement for respiratory support (supplemental oxygen or ventilation).

Main Results:

  • Obesity was linked to increased respiratory support needs during T1 (RR 3.45) and T2 (RR 3.24).
  • This association was not significant during the Omicron wave (T3) (RR 3.08).
  • Findings persisted in unvaccinated children, suggesting vaccination did not explain the diminished association.

Conclusions:

  • Childhood obesity was a risk factor for severe COVID-19 during ancestral and pre-Omicron waves.
  • The association between obesity and severe COVID-19 was lost during the Omicron wave.
  • This shift highlights evolving SARS-CoV-2 variant impacts on pediatric populations, irrespective of vaccination status.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K